Gapping up
In reaction to disappointing earnings/guidance: EXPR +9.2%, TECD +8.6%, XCRA +7.4%, NEPT +3.6%, JKS +3.3%, AVGO +3.2%, PLKI +2.8%, KMPH +1.7%, PANW +1.3%, DSGX +0.7%
M&A news:RALY +43.6% (CA Technologies agrees to acquire Rally Software for $19.50/share), CA +0% (CA Technologies agrees to acquire Rally Software for $19.50/share), NETE +14.5% (confirms acquisition of PayOnline), AVGO +2.9% (confirms BRCM merger, also issued earnings)
Other news: BIOC +18% (announces an abstract at ASCO), OPXA +9.8% (cont strength), IMAX +7.2% (subsidiary IMAX China Holding announces submission of a listing application for a public offering and listing of its shares on the Hong Kong Stock Exchange), ETRM +5.4% (Kevin Douglas disclosed 14.2% active stake in 13D filing), GPRO +5% (unveiled a virtual reality accessory for its Hero4 camera and a quadcopter), NVGN +4.2% (announces the lodgement with the US Patent Office of a key patent covering a novel family of compounds within the Company's anti-tropomyosin drug technology platform), XBIT +3.7% (announces that the FDA has lifted its clinical hold from the Co's IND), AMPE +2.1% ( disclosed that Rosewind subsidiary entered into and closed on an Asset Purchase Agreement with Jazz Pharmaceuticals), GALE +1.9% (cont strength), CSIQ +1.3% (announced it has supplied modules to Turkey's largest PV project), GBSN +1.1% (reported 112 US revenue-generating customers as of May 27, 2015, up 10.3% QoQ)
Analyst comments: ERIC +2.1% (upgraded to Buy from Neutral at Citigroup), RL +2.1% (upgraded to Buy from Neutral at Goldman), WDC +1.7% (upgraded to Buy from Neutral at Goldman), SALE +1.1% (initiated with a Buy at Topeka Capital Mkts), GM +1.1% (upgraded to Equal-Weight from Underweight at Morgan Stanley), PIR +1% (initiated with a Buy at Cantor Fitzgerald), CMG+0.9% (upgraded to Buy at Miller Tabak
)
In reaction to disappointing earnings/guidance: EXPR +9.2%, TECD +8.6%, XCRA +7.4%, NEPT +3.6%, JKS +3.3%, AVGO +3.2%, PLKI +2.8%, KMPH +1.7%, PANW +1.3%, DSGX +0.7%
M&A news:RALY +43.6% (CA Technologies agrees to acquire Rally Software for $19.50/share), CA +0% (CA Technologies agrees to acquire Rally Software for $19.50/share), NETE +14.5% (confirms acquisition of PayOnline), AVGO +2.9% (confirms BRCM merger, also issued earnings)
Other news: BIOC +18% (announces an abstract at ASCO), OPXA +9.8% (cont strength), IMAX +7.2% (subsidiary IMAX China Holding announces submission of a listing application for a public offering and listing of its shares on the Hong Kong Stock Exchange), ETRM +5.4% (Kevin Douglas disclosed 14.2% active stake in 13D filing), GPRO +5% (unveiled a virtual reality accessory for its Hero4 camera and a quadcopter), NVGN +4.2% (announces the lodgement with the US Patent Office of a key patent covering a novel family of compounds within the Company's anti-tropomyosin drug technology platform), XBIT +3.7% (announces that the FDA has lifted its clinical hold from the Co's IND), AMPE +2.1% ( disclosed that Rosewind subsidiary entered into and closed on an Asset Purchase Agreement with Jazz Pharmaceuticals), GALE +1.9% (cont strength), CSIQ +1.3% (announced it has supplied modules to Turkey's largest PV project), GBSN +1.1% (reported 112 US revenue-generating customers as of May 27, 2015, up 10.3% QoQ)
Analyst comments: ERIC +2.1% (upgraded to Buy from Neutral at Citigroup), RL +2.1% (upgraded to Buy from Neutral at Goldman), WDC +1.7% (upgraded to Buy from Neutral at Goldman), SALE +1.1% (initiated with a Buy at Topeka Capital Mkts), GM +1.1% (upgraded to Equal-Weight from Underweight at Morgan Stanley), PIR +1% (initiated with a Buy at Cantor Fitzgerald), CMG+0.9% (upgraded to Buy at Miller Tabak
)